• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Age as limiting factor of the efficacy of itraconazole for treatment of onychomycosis.

作者信息

Fiallo P, Cardo P P

机构信息

Servizio di Immunopatologia Cutanea, Università di Genova, Viale Benedetto XV, 7, I-16132 Genova, Italia.

出版信息

Mycoses. 2001;44(5):191-4. doi: 10.1046/j.1439-0507.2001.00645.x.

DOI:10.1046/j.1439-0507.2001.00645.x
PMID:11486457
Abstract

A clinical study was carried out involving 24 patients between 18 and 64 years of age with disto-lateral onychomycosis of finger and/or toenail in whom intermittent therapy with itraconazole was orally administered for 4 months. A follow-up period of 9 months was instituted to monitor the efficacy of the treatment. Clinical and mycological outcome at the end of the study was correlated with a checklist that included age and sex of the patient, site of infection and species of the causative agent. Nails that were free of disease in both gross and mycological examinations were achieved in 58% of our patients. Age was shown to be the only parameter, among those taken into consideration, that was correlated with the cure rate. The association was found to be statistically significant.

摘要

相似文献

1
Age as limiting factor of the efficacy of itraconazole for treatment of onychomycosis.
Mycoses. 2001;44(5):191-4. doi: 10.1046/j.1439-0507.2001.00645.x.
2
Itraconazole pulse therapy in the treatment of disto-lateral subungual onychomycosis.伊曲康唑脉冲疗法治疗远端侧位甲下型甲癣
J Coll Physicians Surg Pak. 2003 Nov;13(11):618-20.
3
Safety and efficacy of intermittent therapy with itraconazole in finger- and toenail onychomycosis: a multicentre trial.
Mycoses. 1998 Dec;41(11-12):521-7. doi: 10.1111/j.1439-0507.1998.tb00716.x.
4
Intermittent pulse therapy with itraconazole for onychomycosis. Experience in Hong Kong Chinese.
Mycoses. 2000;43(1-2):35-9. doi: 10.1046/j.1439-0507.2000.00551.x.
5
Small-dose itraconazole pulse therapy in the treatment of onychomycosis.
Mycoses. 1997 Dec;40(9-10):397-400. doi: 10.1111/j.1439-0507.1997.tb00258.x.
6
Long-term effectiveness of treatment with terbinafine vs itraconazole in onychomycosis: a 5-year blinded prospective follow-up study.特比萘芬与伊曲康唑治疗甲真菌病的长期疗效:一项为期5年的双盲前瞻性随访研究。
Arch Dermatol. 2002 Mar;138(3):353-7. doi: 10.1001/archderm.138.3.353.
7
An independent comparison of terbinafine and itraconazole in the treatment of toenail onychomycosis.特比萘芬与伊曲康唑治疗趾甲甲真菌病的独立比较。
J Dermatolog Treat. 2003 Dec;14(4):237-42. doi: 10.1080/09546630310017834.
8
A comparison among four regimens of itraconazole treatment in onychomycosis.伊曲康唑治疗甲癣的四种方案比较。
Mycoses. 1999 Apr;42(1-2):93-6. doi: 10.1046/j.1439-0507.1999.00404.x.
9
Clinical and pharmacokinetic investigations of oral intraconazole in the treatment of onychomycosis.
Mycoses. 1999 Apr;42(1-2):79-91. doi: 10.1046/j.1439-0507.1999.00264.x.
10
Fusarium onychomycosis: prevalence, clinical presentations, response to itraconazole and terbinafine pulse therapy, and 1-year follow-up in nine cases.镰刀菌甲癣:9例患者的患病率、临床表现、对伊曲康唑和特比萘芬脉冲疗法的反应及1年随访
Int J Dermatol. 2015 Nov;54(11):1275-82. doi: 10.1111/ijd.12906. Epub 2015 Jul 29.

引用本文的文献

1
On the Basis of Sex: Impact and Treatment of Toenail Onychomycosis in Female Patients.基于性别:女性患者趾甲甲真菌病的影响与治疗
J Clin Aesthet Dermatol. 2023 Oct;16(10):52-57.
2
Variability in Systemic Treatment Efficacy for Onychomycosis: Information That Clinical Studies Do Not Impart to the Office Dermatologist.甲癣全身治疗疗效的变异性:临床研究未告知皮肤科门诊医生的信息。
Skin Appendage Disord. 2018 Aug;4(3):141-144. doi: 10.1159/000481693. Epub 2017 Oct 26.